Prerpints.org logo

You are currently viewing a beta version of our website. If you spot anything unusual, kindly let us know.

Leave Feedback
Preprint
Article

Pepper Fruit Extracts Show Anti-Proliferative Activity against Tumor Cells Altering Their NADPH-Generating Dehydrogenase and Catalase Profiles

Altmetrics

Downloads

111

Views

50

Comments

0

A peer-reviewed article of this preprint also exists.

supplementary.pdf (205.62KB )

Submitted:

20 June 2023

Posted:

21 June 2023

You are already at the latest version

Alerts
Abstract
Cancer is considered nowadays one of the main causes of human death worldwide, being characterized by an alteration of the oxidative metabolism. Many natural compounds with anti-tumor attributes have been described, many of them from plant origin. Among them, capsaicin, which is the molecule responsible for the pungency in hot pepper fruits, has been reported to show antioxidant, anti-inflammatory and analgesic activities, as well as anti-proliferative properties against cancer. Thus, in this work the potential anti-proliferative activity of pepper (Capsicum annuum L.) fruits from diverse varieties with different capsaicin content (California < Piquillo < Padrón < Alegría riojana) against several tumor cell lines (lung, melanoma, hepatoma, colon, breast, pancreas, and prostate) has been investigated. The results showed that the capsaicin content in pepper fruits did not correspond with their anti-proliferative activity against tumor cell lines. By contrast, the greatest activity was promoted by the pepper tissues which contained the lowest capsaicin amount. This indicates that other compounds different from capsaicin have this anti-tumor potentiality in pepper fruits. Based on this, green fruits from the variety Alegría riojana, which has negligible capsaicin levels, was used to study the effect on the oxidative and redox metabolism of tumor cell lines from liver (Hep-G2) and pancreas (MIA PaCa-2). Different parameters from both lines treated with pepper fruit crude extracts were determined including, among others, protein nitration and protein S-nitrosation (two post-translational modifications (PTMs) promoted by nitric oxide), the antioxidant capacity, as well as the activity of the antioxidant enzymes superoxide dismutase (SOD), catalase, and glutathione peroxidase (GPX). Besides, the activity of the NADPH-generating enzymes glucose-6-phosphate dehydrogenase (G6PDH), 6-phosphogluconate dehydrogenase (6PGDH), and NADP-isocitrate dehydrogenase (NADP-ICDH) was followed. Our data revealed that the treatment of both cell lines with pepper fruit extracts altered their antioxidant capacity, enhanced the catalase activity, and considerably reduced the activity of the NADPH-generating enzymes. As a consequence, less H2O2 and NADPH seem to be available to cells, thus avoiding cell proliferation and possibly triggering cell death in both cell lines.
Keywords: 
Subject: Biology and Life Sciences  -   Agricultural Science and Agronomy

1. Introduction

Cancer is considered nowadays one of the main causes of human death worldwide, as a consequence of the interaction of both environmental and genetic factors. Globally, cancer is a polyhedric pathology that implies both genetic alteration through mutations and uncontrolled cell proliferation [1]. It has been also shown that cancer is associated with the alteration of the nitro-oxidative metabolism in the cells, and oxidative stress and oxidative damage episodes greatly contribute to the initiation, development, metastasis, and progression of cancer [1,2,3,4,5,6,7]. This situation of oxidative stress seems to down-modulate gene expression of mechanisms involved in DNA repair, cell proliferation, and the antioxidant machinery [1,6]. In fact, the analysis of the antioxidant enzymes’ profiles has been set as a promising prognostic index in cancer of several organs like lung, bladder, ovaries, and colon [7,8]. Accordingly, strategies and therapies to promote an enhanced and appropriate antioxidant status in the cells have been considered as objectives to be exploited for the treatment of cancer. They include those based on the modulation of the cellular redox state [9,10], such as the epigenetic mechanisms driven by histone deacetylases [4], the photodynamic therapy to regulate the redox balance and the production of reactive oxygen species (ROS) [11], or those addressed to promote the ROS-associated simple summary autophagy, considering that the dysfunction in the autophagy is linked to cancer disease [12].
Alternatively, the supplementation of antioxidants or antioxidant-promoting compounds has been set. Thus, from in vitro and in vivo studies, it has been proposed that isoflavone genistein is a promising agent for cancer chemoprevention with high potentialities for cancer therapy [13]. Likewise, the frequent use of vitamins C and E after the diagnosis of breast cancer has been associated with a lower probability of cancer recurrence, although the authors also showed that the effects of the antioxidants supplementation varied by the type of antioxidant [14]. In this sense, it has been also reported that a meta-analysis made from diverse databases did not support the correlation between antioxidants and the reduction of the risk of breast cancer [15]. And, the lack of clear evidence for the protective role of selenium (Se) and antioxidants against gastrointestinal cancers has been also referenced [16]. Nevertheless, it was proved that dietary Se was oppositely associated with the risk of pancreatic cancer. Moreover, Se supplementation attenuated this association [17], thus confirming the important role of this element, necessary for the glutathione peroxidase function to remove H2O2. Thus, Saha and colleagues [18] found a correlation among nutrition, oxidative stress, and cancer initiation, and assessed the impact of the antioxidant capability against cancer therapy mediated by daily nutrition. In the same way, it was reported that the dietary intake of antioxidants from different plant foods was related to a reduction in the risk of gastric cancer [19].
The NADPH metabolism is also a key point in cancer episodes. Thus, for example, the over-expression of superoxide-generating NADPH oxidase (NOX) proteins in many tissues is associated with the own tissue and DNA damages promoted by ROS, which accompanies the pre-malignant conditions. It has been reported that several NOX isoforms produce ROS and contribute to the initiation and progression of a diversity of solid and haematopoietic malignancies, including colorectal and pancreatic carcinomas [20]. Conversely, it has been proposed that cancer cells require enhanced levels of NADPH for nucleotide synthesis and protection from ROS [21]. With these premises, a mechanism of NADPH homeostasis in cancer cells has been postulated [22], where enzymatic systems such as those from the oxidative phase of pentose phosphate pathway glucose-6-phosphate dehydrogenase (G6PDH), 6-phosphogluconate dehydrogenase (6PGDH), as well as the NADP-isocitrate dehydrogenase (NADP-ICDH) and the NADP-malic enzyme (NADP-ME) could be involved [23,24,25,26,27,28,29].
From the human nutrition point of view, many plant species are sources of both macronutrients (carbohydrates, lipids, proteins, and fiber) and micronutrients with bioactive potential. Whereas macronutrients are mainly used for energy and structural purposes, micronutrients are essential in little amounts to modulate chemical reactions and metabolic processes. Within plant products, fruits and vegetables are useful vehicles for the provision of bioactive compounds, although, in some cases, their specific actions and their identification are still undeciphered. In fact, plants contain a great number of compounds as part of their secondary metabolism, including vitamins (A, C, and E), carotenoids, polyphenols (flavonoids, anthocyanins, tannins, etc.), terpenoids, and alkaloids, among others. Most of these metabolites are abundant and well-recognized antioxidants in plant tissues, but their requirement in the human diet is very low since they mainly have regulatory roles [30].
Pepper (Capsicum annuum L.) is a herbaceous plant species which, besides other relevant crops like tomato (Lycopersicum esculentum), potato (Solanum tuberosum), and aubergine (Solanum melongena), belongs to the Solanaceae family [31,32,33]. Pepper fruit is one of the most consumed horticultural products worldwide with thousands of varieties cultivated nowadays throughout the world. Likewise, pepper fruit is characterized by its high amounts of antioxidants (vitamins C and A), carotenoids, polyphenols (including flavonoids), and capsaicinoids [34]. It has been reported that flavonoids, besides antioxidant capacity, show antibacterial, antifungal, and anticancer effects [35,36,37,38,39,40]. Also, capsaicin, an alkaloid that is exclusive from hot pepper fruits and responsible for their pungency, displays antioxidant, anti-inflammatory, antiproliferative, and analgesic activities. Recently, by the use of untargeted metabolomic approaches, it has been found that pepper (Capsicum annuum) fruits contain a series of compounds with potential therapeutic properties due to the presence, among others, of quercetin and its derivatives, with their content being modulated by nitric oxide (NO) [41]. Particularly, capsaicin appears to play a role at the levels of the transient receptor potential vanilloid type-1 (TRPV1) and the phosphorylation of the tumor suppressor protein p53 [42,43,44,45,46,47,48]. Accordingly, due to the great and diverse consumption of pepper fruits worldwide and their molecular composition, this product might be considered as vectors of bioactive compounds with therapeutic potential [31,49,50].
In this work, the anti-proliferative activity of crude extracts from four pepper fruit varieties (California, Padrón, Piquillo, and Alegría riojana) against seven tumor cell lines (lung, skin, liver, colon, breast, pancreas, and prostate) was investigated. The antioxidant status of liver and pancreas tumor cell lines, incubated with pepper fruit extracts from Alegría riojana, was then analyzed, and the activity profile of catalase, superoxide dismutase, glutathione peroxidase, and several NADPH-generating enzyme systems was followed. This allows an understanding of how the anti-proliferative activity exerted by crude extracts from pepper fruits is related to the antioxidant and redox metabolism of the susceptible tumor cells.

2. Materials and methods

2.1. Plant material and preparation of crude extracts

Pericarp and placenta (Figure 1A) from pepper fruits of the varieties California (Melchor), Padrón, Piquillo, and Alegría riojana were used at both immature green and ripe red stages (Figure 1B) shows the phenotype of the fruits from the pepper varieties used in this work. Plant material was powdered under liquid N2 using an IKA® A 11 BASIC analytical mill (IKA Laboratories Inc; Staufen, Germany). Basically, 1 g of powder was dissolved into 1 mL of pure acetonitrile (AcN), and the samples were shaken for 1 hour at room temperature (RT) with a vortex at maximum speed, and then centrifuged for 45 min at 5,410 g at RT. Afterward, samples were filtered and evaporated under a nitrogen gas stream. Finally, 200 µl of 20% (v/v) dimethylsulfoxide (DMSO) was added to each extract to prepare the pepper fruit homogenates.
Preprints 77161 g001
Figure 1. Plant materials and pepper varieties used in this work, and their capsaicin content. A, Different parts of a representative pepper fruit. B, Pictures of fruits from the four varieties at two ripening stages: immature green and ripe red. Whereas California-Melchor is a sweet pepper fruit type, Piquillo Padrón and Alegría riojana contain different capsaicin levels with the sequence Piquillo <<< Padrón < Alegría riojana. C, Content of total capsacin levels in placenta and pericarp from fruits of the four pepper varieties at two ripening stages. Placenta tissue was processed once seeds were discarded. Data are the means ± SEM of three replicates determined from five fruits of the four varieties and at the two ripening stages. Different letters after each value indicate that differences were statistically significant (ANOVA, p < 0.05). FW, fresh weight. Figure designed from data provided in Palma et al. [51].
Figure 1. Plant materials and pepper varieties used in this work, and their capsaicin content. A, Different parts of a representative pepper fruit. B, Pictures of fruits from the four varieties at two ripening stages: immature green and ripe red. Whereas California-Melchor is a sweet pepper fruit type, Piquillo Padrón and Alegría riojana contain different capsaicin levels with the sequence Piquillo <<< Padrón < Alegría riojana. C, Content of total capsacin levels in placenta and pericarp from fruits of the four pepper varieties at two ripening stages. Placenta tissue was processed once seeds were discarded. Data are the means ± SEM of three replicates determined from five fruits of the four varieties and at the two ripening stages. Different letters after each value indicate that differences were statistically significant (ANOVA, p < 0.05). FW, fresh weight. Figure designed from data provided in Palma et al. [51].
Preprints 77161 g001

2.2. Determination of capsaicin

High-Performance Liquid Chromatography-Electrospray Mass Spectrometry (HPLC-ES/MS) was applied (HPLC-MS), using commercial capsaicin (Cayman Chemical, Ann Arbor, MI, USA) as standard as described earlier [51]. Three replicates for each pepper fruit sample (pericarp and placenta from the four varieties at the two ripening stages, green and red) were assayed. Basically, samples (0.5 g) were ground into a powder under liquid N2 and suspended into 2 mL AcN containing 100 ppm N-[(3,4-dimethoxyphenyl)methyl]-4-methyl-octanamide (DMBMO), as an internal standard. In our experimental conditions, an XBridge 2.1 × 10 mm pre-column and an XBridge 2.1 × 100 mm C18 3.5 µm column (Waters Corporation, Milford, MA, USA) were used connected to an Alliance 2695 HPLC system coupled to a Micromass Quattro micro API triple quadrupole mass spectrometer (Waters). The retention time for capsaicin in our experimental conditions was 1.88 min, and the concentration of capsaicin was expressed as μg g−1 of fresh weight [51].

2.3. Tumor cell lines, anti-proliferative activity assays, and preparation of crude extracts

The following cell lines were tested: Lung, A549; Melanoma (skin), A2058; Hepatoma (liver), Hep-G2; Colon, HT-29; Breast, MCF-7; Pancreas, MIA PaCa-2; and Prostate, PC-3. To determine the anti-proliferative activity, cells (about 10,000) from each line were incubated with several dilutions (1–1,024 fold) of pepper fruit samples in a final volume of 100 μL in 96-well plates. Different amounts (8 – 1,000 μM/well) of commercial capsaicin (Cayman Chemical) were used as positive control, considering previous reports on the anti-proliferative activity of this compound against tumor cell lines [42,43,44,45,46,47,48]. Then, the MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] test was used after 72 h incubation of cells with pepper fruit extracts [52]. Under these conditions, the antiproliferative activity (0 - 100%) was determined. Also, in assays conducted to the analysis of the effect of pepper fruit samples (variety Alegría riojana) on the ROS and antioxidant metabolism of Hep-G2 and MIA PaCa-2 tumor cell lines, the IC50, as the amount of pepper fruit which reduced by 50% in the cell viability, was estimated.
For the biochemical assays after the incubation for 3 d of tumor lines with pericarp of pepper fruits (0.12-0.15 g dry weight), cells (46 x 106) from Hep-G2 and MIA PaCa-2 were resuspended and homogenized in extraction buffer consisting in 50 mM Tris-HCl pH 7.8, 0.1 mM EDTA, 0.1% (v/v) Triton X-100, 10 % (v/v) glycerol and 1mM PMSF. Then, crude extracts were centrifuged at 15,000 g for 30 min at 4ºC. Supernatants were used for further assays. Protein concentration in supernatants was determined with the aid of Pierce™ BCA Protein assay kit, which is based on bicinchoninic acid (BCA) for colorimetric detection and quantification of total protein, using bovine serum albumin as standard [53].

2.4. Enzyme activities

Catalase activity (EC 1.11.1.6) was determined by following the decomposition of H2O2 at 240 nm as described by Aebi [54]. NADP-dependent dehydrogenase (NADP-DH) activities were determined spectrophotometrically by recording the reduction of NADP at 340 nm for 30 min. Assays were performed at 25 ºC in a reaction buffer (1 mL) containing 50 mM HEPES, pH 7.6, 2 mM MgCl2, and 0.8 mM NADP, and the reaction was initiated by the addition of the specific substrates. Thus, G6PDH (EC 1.1.1.49) activity was initiated with 5 mM glucose-6-phosphate; to determine 6PGDH (EC 1.1.1.44) activity, the substrate was 5 mM 6-phosphogluconate; and for NADPH-ICDH (EC 1.1.1.42) activity, the reaction was initiated by the addition of 10 mM 2R,3S-isocitrate [55,56].
For the analysis of the superoxide dismutase (SOD; EC 1.15.1.1) isoenzyme profile, 20 µg of protein from cell extracts were separated by non-denaturing PAGE on 10% acrylamide gels. The isoenzymes were detected using the staining method based on the photochemical reduction of nitroblue tetrazolium (NBT) by superoxide radicals (O2•−). Isoenzymes were visualized as achromatic bands over a purple background [57]. The nature of each SOD isozyme was determined through the incubation of gels with 5 mM KCN previous to the staining method. Thus, copper, zinc-containing SODs (CuZnSODs) are inhibited by KCN, whereas manganese-containing SODs (MnSODs) are resistant to that inhibitor [51].
The analysis of the glutathione peroxidase (GPX; EC 1.11.1.9) isozymes was carried out as described by Lin et al. [58] with some modifications. Samples (30 µg of protein) were separated by non-denaturing PAGE on 6% acrylamide gels. After electrophoresis, gels were submerged for 20 min twice in 50 mM Tris-HCl, pH 7.9. Then, gels were soaked in the same buffer containing 13 mM GSH (reduced glutathione) and 0.004% (v/v) H2O2 with gentle shaking and darkness conditions for 10-20 min at room temperature. After rinsing with distilled water, gels were incubated with 1.2 mM NBT and 1.6 mM phenazine metasulfate (PMS) in distilled water, until the appearance of achromatic bands over a purple background. Finally, gels were washed with several changes of water for destaining [58].

2.5. SDS-PAGE and immunoblot analyses

SDS-PAGE was performed in 4-20% precast polyacrylamide gels using a Mini-Protean IV electrophoresis cell (Bio-Rad, Hercules, CA, USA). For immunoblot analyses, proteins were transferred from gels onto PVDF membranes (0.45-µm) using a Trans-Blot® Turbo TMTransfer System (Bio-Rad, Hercules, CA, USA). Cross-reactivity assays with different polyclonal and monoclonal antibodies were developed. Thus, nitrated proteins were detected by using a polyclonal antibody against nitrotyrosine (NO2-Tyr, Sigma Aldrich) (dilution 1:500) and a monoclonal antibody against nitrotryptophan (NO2-Trp, Invitrogen) (dilution 1:1000); S-nitrosated proteins were detected by incubating with a polyclonal antibody against S-nitrosocysteine (SNO-Cys) (dilution 1:500); and for the detection of glutathionylated proteins, a polyclonal antibody against glutathione (anti-GSH) (dilution 1:1000) was used; the presence of MAPK/ERK kinases was detected using the monoclonal antibody anti-ERK1/2 (BDbiosciences) (dilution 1:1000).
For immunodetection, an enhanced chemiluminescence kit (Clarity™Western ECL Substrate, BioRad) was used according to the manufacturer’s instructions. Chemiluminescence was detected using a ChemicDocTM XRS imaging system (BioRad).

2.6. Antioxidant capacity assay

Total antioxidant capacity (TAC), was measured in cell samples (20 µl) using an e-BQC laboratory device (Bioquochem) according to the manufacturer’s instructions. This method is based on the measurement of the redox potential sample, directly providing the antioxidant capacity as the charge (μC) of the electrons that are able to be donated to a free radical to be neutralized. A standard curve was made using ascorbate and the values in each sample are expressed as ascorbate equivalents (AsA Eq, μM).

2.7. Statistical analysis

The statistical analysis was performed using the software Statgraphics Centurion program. Pairwise comparisons were made by a Student’s t-test, and ANOVA was used for comparisons among capsaicin analysis. Values for p<0.05 were considered statistically significant.

3. Results

3.1. Crude extracts from pepper fruit show anti-proliferative activity against tumor cell lines

The anti-proliferative activity of crude extracts pericarp and placenta from green (immature) and red (ripe) pepper fruits of four varieties containing different capsaicin content (C, California; Pi, Piquillo; P, Padrón; AR, Alegría riojana) was assayed using seven tumor cell lines. The sequence of capsaicin content, as previously reported was: placenta from red AR fruits > placenta from red P > placenta from green AR = placenta from green P > pericarp from red AR > pericarp from red P > pericarp from green AR > pericarp from green P > placenta from green Pi > placenta from red Pi > pericarp from green Pi > pericarp from red Pi. None of the extracts from California, which belongs to the sweet pepper fruits contained capsaicin (Figure 1C) [51]. Interestingly, it was demonstrated that green fruits from the four pepper varieties and with the lowest capsaicin levels displayed the highest anti-proliferative activity against the seven tumor cell lines, whereas samples with quite high capsaicin contents (above 250 μg/g fresh weight) barely reached 50% anti-proliferative activity (Figure 2). As a control, the assays were also performed using commercial capsaicin to test the negative effect of this compound in the viability of the used tumor cell lines. Thus, as given in Table 1, pure capsaicin displayed IC50 values ranging from 28.0 – 72.0 μM depending on the cell lines assayed. The amount of capsaicin loaded in each well is also indicated in the table, and it ranged from 0.86 to 2.2 μg.
Preprints 77161 g002
Figure 2. Antiproliferative activity and capsaicin content of crude extracts from fruits of four pepper varieties against seven tumor cell lines. The antiproliferative activity is expressed as % of dead cells after the treatment, and capsaicin content, as μg/g fresh weight (FW), determined in the samples of pepper fruits used in the assays. Plant materials assayed in this experiment and their corresponding codes include pericarp (PE) and placenta (PL) from green (g) and red (r) pepper fruits from the varieties California (C), Piquillo (Pi), Padrón (P) and Alegría riojana (AR). The cell lines used corresponded to tumors from lung (A549), melanoma (A2058), hepatoma (Hep-G2), colon (HT-29), breast (MCF-7), pancreas (MIA PaCa-2), and prostate (PC-3). .
Figure 2. Antiproliferative activity and capsaicin content of crude extracts from fruits of four pepper varieties against seven tumor cell lines. The antiproliferative activity is expressed as % of dead cells after the treatment, and capsaicin content, as μg/g fresh weight (FW), determined in the samples of pepper fruits used in the assays. Plant materials assayed in this experiment and their corresponding codes include pericarp (PE) and placenta (PL) from green (g) and red (r) pepper fruits from the varieties California (C), Piquillo (Pi), Padrón (P) and Alegría riojana (AR). The cell lines used corresponded to tumors from lung (A549), melanoma (A2058), hepatoma (Hep-G2), colon (HT-29), breast (MCF-7), pancreas (MIA PaCa-2), and prostate (PC-3). .
Preprints 77161 g002
Table 1. IC50 determined for each of the tumor cell lines incubated with commercial capsaicin. IC50 was defined as the amount of capsaicin, prepared in methanol solution, which reduced by 50% the cell viability.
Table 1. IC50 determined for each of the tumor cell lines incubated with commercial capsaicin. IC50 was defined as the amount of capsaicin, prepared in methanol solution, which reduced by 50% the cell viability.
Cell lines IC50
(μM capsaicin)		 Capsaicin in the assay (μg/well)
A549 40.70 1.243
A2058 53.00 1.618
Hep-G2 28.00 0.855
HT-29 51.50 1.573
MCF-7 33.15 1.012
MIA PaCa-2 61.25 1.870
PC-3 72.20 2.199
In order to seek the specific mechanisms where this anti-proliferative activity resides, green pericarps from cultivar Alegría riojana (with almost negligible capsaicin content) were set, and the IC50 index for Hep-G2 and MIA PaCa-2 tumor cells was determined. Thus, for Hep-G2, it was found that 15.48 mg of pepper fruit fresh weight provoked 50% lethality in 10,000 cells (Figure 3A), whereas in MIA PaCa-2 cells, this parameter was much lower, 17.10 mg/10,000 cells (Figure 3B). Then, the potential effect of pepper crude extracts on the tumor stage of cells was assayed by using an antibody against ERK1/2, two related protein-serine/threonine kinases which are used as markers of tumor events through their participation in the Ras-Raf-MEK-ERK signal transduction cascade [59]. Thus, as observed in Figure 3C, in Hep-G2 cells, this marker showed little changes, whilst, in pancreas tumor cells, an enhancement of the protein with higher size was detected.
Preprints 77161 g003
Figure 3. IC50 and level of the tumor marker ERK 1/2 from Hep-G2 and MIA PaCa-2 tumor cell lines after the incubation with pepper fruit crude extracts from the variety Alegría riojana. IC50 was defined as the amount of pepper fruit that reduced by 50% the cell viability. A, IC50 in Hep-G2 cells. B, IC50 in MIA PaCa-2 cells. C, Detection of the tumor marker ERK 1/2 (related protein-serine/threonine kinases 1 and 2) in Hep-G2 and MIA PaCa-2 cells untreated (C) and treated (T) with crude extracts from pepper fruits. Polypeptides were separated by SDS-PAGE in 4-20% precast polyacrylamide gels and blotting assays were done using a monoclonal antibody against ERK1/2 proteins (dilution 1:1000). Molecular weight markers are indicated in the left.
Figure 3. IC50 and level of the tumor marker ERK 1/2 from Hep-G2 and MIA PaCa-2 tumor cell lines after the incubation with pepper fruit crude extracts from the variety Alegría riojana. IC50 was defined as the amount of pepper fruit that reduced by 50% the cell viability. A, IC50 in Hep-G2 cells. B, IC50 in MIA PaCa-2 cells. C, Detection of the tumor marker ERK 1/2 (related protein-serine/threonine kinases 1 and 2) in Hep-G2 and MIA PaCa-2 cells untreated (C) and treated (T) with crude extracts from pepper fruits. Polypeptides were separated by SDS-PAGE in 4-20% precast polyacrylamide gels and blotting assays were done using a monoclonal antibody against ERK1/2 proteins (dilution 1:1000). Molecular weight markers are indicated in the left.
Preprints 77161 g003

3.2. Pepper fruit extracts slightly alter the nitro-oxidative status of tumor cells

Posttranslational modifications (PTMs) such as tyrosine (Tyr) and tryptophan (Trp) nitration, as well as oxidative PTMs (oxiPTMs), including S-nitrosation and S-glutathionylation, were analyzed, to follow the nitro-oxidative status in tumor cell lines incubated with crude extracts from the Alegría riojana cultivar. Figure 4 and Figure 5 show the main polypeptides from both tumor cell lines which cross-react with antibodies against nitro-tyrosine (NO2-Tyr), nitro-tryptophan (NO2-Trp), nitroso-cysteine (CysNO) and glutathione. As observed, several proteins seem to be post-translationally modified by the treatment of cells with pepper fruit extracts. Thus, the expression of Tyr-nitrated proteins studied in Hep-G2 and MIA PaCa-2 tumor cell lines showed little differences in both cell lines after the incubation with crude extracts from pepper fruits (Figure 4). As depicted in Figure 4A, in Hep-G2 cells five major polypeptide bands (PHY 1 - PHY 5; Supplementary Table 1) were detected with PHY 4 being visibly reduced after the treatment. Likewise, in MIA PaCa-2 cells, nine main polypeptide bands (PMY 1 - PMY 9; Supplementary Table 1) were observed in both control and treated cells. In this latter case, PPT 1 showed a decrease after treatment, whilst a notable increase was observed in polypeptides PMW 6 and PMW 7 after cells were incubated with the fruit extracts.
The pattern of Trp-nitrated proteins from both cell lines was also investigated (Figure 4B). In the western blotting assays with Hep-G2 cells, eight polypeptide bands (PHW 1-PHW 8; Supplementary Table 2) were mostly visible after the use of the antibody against NO2-Trp, with no intensity changes after the incubation with pepper fruit extracts. Likewise, 9 cross-reacting bands (PMW 1 - PMW 9; Supplementary Table 2) appeared in MIA PaCa-2 control plants and no significant changes underwent in cells subjected to the treatment.
Concerning S-nitrosated proteins, different profiles were obtained depending on the cell lines (Figure 5A). Thus, in Hep-G2 cell six polypeptides (PHC 1 - PHC 6; Supplementary Table 3) cross-reacted with the antibody against nitroso-cysteine (SNO-Cys), with PHC 6 being the most abundant one. The incubation with pepper fruit crude extract did not provoke changes in the S-nitrosation pattern. In MIA PaCa-2 cells five major polypeptides were visible (PMC 1 - PMC 5; Supplementary Table 3) and no changes were detected either after the treatment. The potential PTM by glutathionylation was also followed in our experimental design. In Hep-G2 cells, nine polypeptides (PHG 1 - PHG 9; Supplementary Table 4) were found to recognize the antibody against glutathione (Anti GSH), where PHG 1 was the most prominent. The number and intensity of these polypeptides did not change after the treatment of cells with pepper extracts (Figure 5B). Regarding pancreas cells, six polypeptides were found (PMG 1 - PMG 6; Supplementary Table 4), and PMG 3 and PMG 6 slightly decreased in cells subjected to pepper treatment.
Preprints 77161 g004
Figure 4. Detection of tyrosine (NO2-Tyr, panel A) and tryptophan (NO2-Trp, panel B) nitrated polypeptides from Hep-G2 and MIA PaCa-2 tumor cell lines after the incubation with pepper fruit crude extracts from the variety Alegría riojana. Polypeptides were separated by SDS-PAGE in 4-20% precast polyacrylamide gels and blotting assays were done using a polyclonal antibody against nitro-tyrosine (NO2-Tyr, dilution 1:500), and a monoclonal antibody against nitro-tryptophan (NO2-Trp, dilution 1:1000). C, untreated cells. T, treated cells. PHY, Polypeptide from Hep-G2 cells with nitrated Tyr (Y). PMY, Polypeptide from MIA PaCa-2 cells with nitrated Tyr (Y). PHW, Polypeptide from Hep-G2 cells with nitrated Tryp (W). PMT, Polypeptide from MIA PaCa-2 cells with nitrated Tryp (W).
Figure 4. Detection of tyrosine (NO2-Tyr, panel A) and tryptophan (NO2-Trp, panel B) nitrated polypeptides from Hep-G2 and MIA PaCa-2 tumor cell lines after the incubation with pepper fruit crude extracts from the variety Alegría riojana. Polypeptides were separated by SDS-PAGE in 4-20% precast polyacrylamide gels and blotting assays were done using a polyclonal antibody against nitro-tyrosine (NO2-Tyr, dilution 1:500), and a monoclonal antibody against nitro-tryptophan (NO2-Trp, dilution 1:1000). C, untreated cells. T, treated cells. PHY, Polypeptide from Hep-G2 cells with nitrated Tyr (Y). PMY, Polypeptide from MIA PaCa-2 cells with nitrated Tyr (Y). PHW, Polypeptide from Hep-G2 cells with nitrated Tryp (W). PMT, Polypeptide from MIA PaCa-2 cells with nitrated Tryp (W).
Preprints 77161 g004
Preprints 77161 g005
Figure 5. Detection of S-nitrosated (SNO-Cys, panel A) and glutathionylated (panel B) polypeptides from Hep-G2 and MIA PaCa-2 tumor cell lines after the incubation with pepper fruit crude extracts from the variety Alegría riojana. Polypeptides were separated by SDS-PAGE in 4-20% precast polyacrylamide gels and blotting assays were done using a polyclonal antibody against S-nitrosocysteine (SNO-Cys, dilution 1:500) and a polyclonal antibody against glutathione (anti-GSH, dilution 1:1000). C, untreated cells. T, treated cells. PHC, Polypeptide from Hep-G2 cells with nitrosated Cys (C). PMC, Polypeptide from MIA PaCa-2 cells with nitrated nitrosated Cys (C). PHG, Polypeptide from Hep-G2 cells Glutathionylated. PMG, Polypeptide from MIA PaCa-2 cells Glutathionylated.
Figure 5. Detection of S-nitrosated (SNO-Cys, panel A) and glutathionylated (panel B) polypeptides from Hep-G2 and MIA PaCa-2 tumor cell lines after the incubation with pepper fruit crude extracts from the variety Alegría riojana. Polypeptides were separated by SDS-PAGE in 4-20% precast polyacrylamide gels and blotting assays were done using a polyclonal antibody against S-nitrosocysteine (SNO-Cys, dilution 1:500) and a polyclonal antibody against glutathione (anti-GSH, dilution 1:1000). C, untreated cells. T, treated cells. PHC, Polypeptide from Hep-G2 cells with nitrosated Cys (C). PMC, Polypeptide from MIA PaCa-2 cells with nitrated nitrosated Cys (C). PHG, Polypeptide from Hep-G2 cells Glutathionylated. PMG, Polypeptide from MIA PaCa-2 cells Glutathionylated.
Preprints 77161 g005

3.3. ROS metabolism in tumor cells under pepper fruit treatment

Trying to unravel and understand how oxidative metabolism was modulated under pepper treatment in both tumor cells lines, Hep-G2 and MIA PaCa-2, this work also focused on a set of antioxidant enzymes such as catalase (CAT), superoxide dismutase (SOD), and glutathione peroxidase (GPX). Additionally, the total antioxidant capacity was evaluated in both lines. Thus, as shown in Figure 6A, this latter parameter showed an opposite trend after the treatment with pepper fruit extracts depending on the tumor line. Thus, in Hep-G2 cells the treatment triggered a significant increase in QT. Nevertheless, the opposite tendency was observed in MIA PaCa-2 cells, where the treatment caused a slight although significant decrease in QT.
Catalase activity, a peroxisomal enzyme associated with the scavenging of H2O2 that is converted into H2O and O2, was increased after the treatment with pepper fruits (Figure 6B). Thus, after the treatment of tumor cells, the activity rose by up to 54 % in Hep-G2 and 182% in MIA PaCa-2 cells. Following further analysis of the H2O2 metabolism, the activity of the GPX isoenzymatic system under pepper fruit treatment was analyzed in both types of tumor cell lines by non-denaturing PAGE (Figure 7A). Thus, globally four GPX isozymes were detected, designated GPX I – GPX IV according to their increasing electrophoretic mobility. In Hep-G2 cells, GPX III and GPX IV were detected, and the activity of both isoenzymes was slightly reduced after the treatment of cells with pepper fruit extracts. On the other hand, in MIA PaCa-2, GPX I, GPX II, and GPX IV were observed. The two slower isozymes were somehow negatively affected by the treatment, whereas GPX IV did not vary (Figure 7A).
Preprints 77161 g006
Figure 6. Total antioxidant activity and catalase activity from Hep-G2 and MIA PaCa-2 tumor cell lines after the incubation with pepper fruit crude extracts from the varietyAlegría riojana. A, Total antioxidant activity expressed as ascorbate equivalents. B, Catalase activity. Data are expressed as the means of at least three independent experiments ± SEM. Asterisks denote significant differences in comparisons of treated cells to untreated (control) ones at a p< 0.05 (Student t-test).
Figure 6. Total antioxidant activity and catalase activity from Hep-G2 and MIA PaCa-2 tumor cell lines after the incubation with pepper fruit crude extracts from the varietyAlegría riojana. A, Total antioxidant activity expressed as ascorbate equivalents. B, Catalase activity. Data are expressed as the means of at least three independent experiments ± SEM. Asterisks denote significant differences in comparisons of treated cells to untreated (control) ones at a p< 0.05 (Student t-test).
Preprints 77161 g006
The SOD isoenzymatic pattern was also investigated as a consequence of the incubation of both cell lines with pepper fruit extracts. Overall, four SOD isozymes were identified, two manganese-containing SODs (MnSOD I and MnSOD II), and two copper zinc-containing SODs (CuZnSOD I and CuZnSOD II) according to their sensitivity to cyanide (Figure 7B). MnSODs are resistant to CN-, whereas CuZnSODs are sensitive. In Hep-G2, MnSOD II and CuZnSOD II were only visible, wilst in MIA PaCa-2 cell the four isozymes could be detected, with CuZnSOD I being the most abundant. None of these SOD isozymes were influenced by the treatment of cells with crude extracts from pepper fruits.
Preprints 77161 g007
Figure 7. Glutathione peroxidase (GPX) and superoxide dismutase (SOD) isoenzymes from Hep-G2 and MIA PaCa-2 tumor cell lines after the incubation with pepper fruit crude extracts from the variety Alegría riojana. Proteins (20-30 mg, see materials and methods) were separated by non-denaturing PAGE in 6% (GPX) and 10% (SOD polyacrylamide gels, and activity was detected in gels by specific staining methods. A, GPX isoenzymatic activity. B, SOD isoenzymatic activity. C, untreated cells. T, cells treated with pepper fruit crude extracts.
Figure 7. Glutathione peroxidase (GPX) and superoxide dismutase (SOD) isoenzymes from Hep-G2 and MIA PaCa-2 tumor cell lines after the incubation with pepper fruit crude extracts from the variety Alegría riojana. Proteins (20-30 mg, see materials and methods) were separated by non-denaturing PAGE in 6% (GPX) and 10% (SOD polyacrylamide gels, and activity was detected in gels by specific staining methods. A, GPX isoenzymatic activity. B, SOD isoenzymatic activity. C, untreated cells. T, cells treated with pepper fruit crude extracts.
Preprints 77161 g007

3.4. Pepper fruit treatment disturbs the NADPH-generating systems in tumor cells

The metabolism of NADPH has been reported to be of relevance in tumor cell lines. Thus, the behaviour of three main NADPH enzymatic sources was studied in this work. The activity of glucose-6-phosphate dehydrogenase (G6PDH), 6-phosphogluconate dehydrogenase (6PGDH), and NADP-dependent isocitrate dehydrogenase (NADP-ICDH) were significantly reduced after the incubation of both Hep-G2 and MIA PaCa-2 cell lines with crude extracts from Alegría riojana pepper fruits. The incubation with pepper fruit extract inhibited G6PDH activity up to 63% in Hep-G2 cell lines and 40% in MIA PaCa-2 lines (Figure 8A). A similar tendency was observed in 6PGDH and NADP-ICDH; treatment of tumor cells with pepper fruit extract provoked significant inhibition of 6PGDH activity in both cell lines by up to ≈80% (Figure 8B). Likewise, Hep-G2 and MIA PaCa-2 subjected to treatment with pepper fruit extract showed significant inhibition of NADP-ICDH activity, by 77% and 48%, respectively (Figure 8C).
Preprints 77161 g008
Figure 8. Activity of NADPH-generating enzymes from Hep-G2 and MIA PaCa-2 tumor cell lines after the incubation with pepper fruit crude extracts from the variety Alegría riojana. A, Glucose-6-phosphate dehydrogenase (G6PDH). B, 6-Phosphogluconate dehydrogenase (6PGDH). C, NADP-dependent isocitrate dehydrogenase (NADP-ICDH). Data are expressed as the means of at least three independent experiments ± SEM. Asterisks denote significant differences in comparisons of treated cells to untreated (control) ones at a p< 0.05 (Student t-test).
Figure 8. Activity of NADPH-generating enzymes from Hep-G2 and MIA PaCa-2 tumor cell lines after the incubation with pepper fruit crude extracts from the variety Alegría riojana. A, Glucose-6-phosphate dehydrogenase (G6PDH). B, 6-Phosphogluconate dehydrogenase (6PGDH). C, NADP-dependent isocitrate dehydrogenase (NADP-ICDH). Data are expressed as the means of at least three independent experiments ± SEM. Asterisks denote significant differences in comparisons of treated cells to untreated (control) ones at a p< 0.05 (Student t-test).
Preprints 77161 g008

4. Discussion

Plants have been always considered as health sources for humans, due to the great amount of their exclusive secondary metabolites which positively interact our physiological functions [30,60,61,62]. Capsaicin (8-methyl-N-vanillyl-trans-6-nonenamide) is an alkaloid compound with a phenyl-propanoid nature which is exclusively present in fruits from hot hot Capsicum (pepper) species and where the pungency trait from those products resides [51,63]. It has been shown that capsaicin shows antioxidant activity, but it also functions as an analgesic with certain roles against infectious diseases in the nervous, cardiovascular, and immune systems, as well as in inflammation, obesity, and cancer episodes [41,43,44,64,65]. It has been reported that in many cancers capsaicin displays proapoptotic activity promoted by the TRPV1 (transient receptor potential vanilloid type-1) channel. Furthermore, this chemical appears to also promote the phosphorylation of the tumor suppressor protein p53, which provokes its activation [41,43,45,46,47]. TRPV1 was identified as the neuronal receptor for harmful stimuli which may allow the development of treatment of chronic pains including cancer [42,48]. Accordingly, in this study, the potential anti-proliferative activity of crude extract from capsaicin-containing hot pepper fruits was evaluated using several tumor cell lines, and the influence of such pepper homogenates in the antioxidant metabolism of such pathogenic cells was investigated.
As a first unexpected discovery, it was found that not all pepper fruits/tissues which contain the highest capsaicin levels [51] displayed the greatest anti-proliferative activity. Conversely, the fruit portion that totally inhibited the growth of cell lines corresponded to the green pericarp from the four varieties used (California-Melchor, Piquillo, Padrón, and Alegría riojana). Capsaicin is synthesized in the placenta tissue of fruits and it migrates towards the pericarp as the fruit ripens. Accordingly, in hot pepper fruits, the capsaicin levels basically show the following sequence from the most to the less concentrated tissues: placenta from ripe red fruits > pericarp from ripe red fruits > placenta from immature green fruits > pericarp from green fruits. Fruits from sweet pepper do not contain capsaicin in either placenta or pericarp. Thus, in our study, the green pericarp from the California-Melchor sweet variety displayed the same high anti-proliferative activity as the green pericarp of Alegría riojana, a variety whose fruit is highly pungent when they ripe [51,63]. In our assay conditions, when the pericarp of green fruits from Alegría riojana where used to determine the IC50 index for Hep-G2 and MIA PaCa-2 cells, and considering the capsaicin content determined in such tissue previously (8.55 μg capsaicin/g tissue) [51], values of 0.13 and 0.15 μg per well, respectively, were estimated. When the assays were carried out with pericarps from red fruit of the same pepper variety (766.26 μg capsaicin/g tissue), about 9.58 μg capsaicin per well (100 μL) was used, a value much higher than that obtained when pure capsaicin was assayed (Table 1). However, very little anti-proliferative activity was shown by this last plant material. This indicates that, although capsaicin was clearly proved to display inhibitory effects on the viability of cells when this compound is present in the pepper fruit material, the effect does not parallel the capsaicin one, but it rather seems that other compounds present in the green tissue are responsible for the anti-proliferative activity. Recently, a series of compounds with anti-carcinogenic potential or related to cancer episodes have been detected in pepper fruits by metabolomic approaches. It was reported that the concentration of those molecules was higher in immature green fruits than in ripe red ones, and they include quercetin, tryptophan (melatonin precursor), and phytosphingosine [41 and references therein, 63]. Thus, new perspectives in the search of for plant metabolites with anti-tumor properties are opened through the combination of metabolomics and biological assays, a research field that can provide a panel of crops with nutraceutical potentialities.
Once preliminary and discriminating assays were performed, green fruits from the Alegría riojana variety were set to investigate their effect on the ROS and NADPH metabolism of tumor cells from Hep-G2 and MIA PaCa-2 lines. Apparently, the progression of cancer does not appear to be affected in Hep-G2 cells by the treatment with the pepper crude extract, since no changes were observed in the ERK1/ERK2 levels. ERK1 and ERK2 are related protein-serine/threonine kinases that take part in the signal transduction cascade associated with a great number of processes, among which cell adhesion, cell cycle progression, cell migration, cell survival, differentiation, metabolism, proliferation, and transcription are the best known [59]. Besides, it has been reported that this transduction cascade is increased in about one-third of all human cancers [65]. In the case of MIA PaCa-2 cells, the higher abundance of the larger subunit may indicate that the tumor events are favored by the treatment, and more research is necessary to clearly define the real tumoral status of those cells.
Cancer processes are commonly linked to altered oxidative metabolism in the cells, with oxidative damages occurring through the initiation, development, metastasis, and progression of the pathology [1,2,3,4,5,6,7]. As a consequence of this oxidative stress, post-translational modifications (PTMs) promoted by nitric oxide (NO) have been reported to take part in cancer [66,67]. It has been also reported that the alteration in the profiles of the nitration, S-nitrosation, and carbonylation of proteins, as a consequence of a NO-dependent oxidative/nitrosative stress, was associated with a reduction of cell survival in a hepatoma cell line [68]. Nitration of proteins is an irreversible PTM that occurs by the addition of a NO2- group to certain either tyrosines (NO2-Tyr) or tryptophan (NO2-Trp) protein residues, whereas S-nitrosation undergoes by the direct addition of NO to some cysteine residues in a reversible way [69]. The results reported show that, excepting few polypeptides, the profile of nitrated proteins at both tyrosine or tryptophan residues did not vary, and the same occur in the case of S-nitrosated proteins. This indicates that, under our experimental conditions, no remarkable oxidative events seem to take place in both cell lines after the incubation with pepper fruit crude extracts. Likewise, no events of glutathionylation (another type of PTM characterized by the addition of glutathione to some cysteine residues) seem to occur after the treatment, although this PTM has also been related to cancer [70,71].
Since cancer causes alteration in the oxidative metabolism, a broader analysis of how the treatment with extracts from pepper fruits influenced the oxidative and the redox metabolism of the two cell lines was aimed in this work. Thus, it was observed that the treatment provoked significant changes in the total antioxidant capacity of both cell lines, although with an opposite trend. We further studied the isozyme profiles of the superoxide dismutase and the glutathione peroxidase systems. In both types of cells, different isoenzyme patterns were observed for GPX and SOD depending on the organ, either the liver or pancreas. Concerning SOD, which scavenges superoxide radicals (O2•−) and converts them into H2O2 plus O2, MnSOD II, and CuZnSOD II were shared by both organs, although the activity in MIA PaCa-2 was almost negligible. On the contrary, the SOD isozymes present in the pancreas cells were undetected in hepatoma cells. This is an interesting issue that deserves attention, since this may indicate different regulation at the organ, and perhaps developmental levels, and this could be essential for the progress of a localized cancer to metastasis. Thus, it has been reported that in colorectal adenocarcinoma and its liver metastases, the differences in mRNA and protein levels of SOD isoenzymes indicate that SOD takes part in the adaptation of tumor cells to oxidative stress. This situation helps keep a certain level of ROS, necessary for appropriate cell proliferation. Furthermore, the expression of SOD isoenzymes seemed to be regulated both at transcriptional and posttranscriptional levels [72]. The role of SODs, especially the MnSOD type has been thoroughly reported as a therapy practice in cancer disease [73,74,75]. Likewise, the isoenzyme profile of GPX, a system that reduces H2O2 to H2O using GSH as an electron donor, was distinct in liver and pancreas tumor cells. Only GPX IV was shared by Hep-G2 and MIA PaCa-2 cells, whereas GPX III was exclusive of hepatoma cells and GPX I and GPX II were only detected in pancreas cells. To our knowledge, neither the isoenzyme profile of GPX nor the potential use of the different isozymes (GPX I – GPX IV) as antioxidant markers in cancer cells from different organs have been reported so far. Our results did not show visible differences in the GPX isoenzymatic activity either in Hep-G2 and MIA PaCa-2 cell lines. However, GPX activity has been reported to be modified in cancerous cells and tissues [76,77,78,79,80,81].
Catalase is the main H2O2 scavenging system which in eukaryotes is localized in peroxisomes. Thus, by virtue of its enzymatic activity, catalase is called to be a key point in many processes where H2O2 may promote oxidative damages, but also in those situations where this species plays a role as a signaling molecule in many physiological situations [81 and references therein]. Catalase has been considered a remarkable enzyme system in the research of cancer and its potential chemotherapy [73,83,84,85]. In our study, the treatment with pepper fruit extracts promoted a substantial increase of catalase activity of the two cell lines, which could scavenge the high H2O2 concentrations which lead to cancer-associated oxidative stress, and help to arrest the tumor evolution.
The NADPH metabolism has been proposed to play important roles in cancer [22], where NADPH-generating enzymes from the pentose phosphate pathway (G6PDG and 6PGDH), as well as the NADP-ICDH and NADP-ME are relevant [23,24,25,26,27,28,29]. In this sense, the considerable decrease of the G6PDH, the 6PGDH, and the NADP-ICDH in both Hep-G2 and MIA PaCa-2 cells after the treatment with pepper fruit extracts implies lower NADPH availability in those cells, thus limiting their evolution to advanced tumor stages.
In Figure 9, a model of how Hep-G2 and MIA PaCa-2 tumor cell lines seem to operate after they are incubated with pepper fruit extracts is shown. The higher catalase activity contributes to diminishing the H2O2 levels. This, combined to lower G6PDH, 6PGDH, and NADP-ICDH activities which lead to a decreased NADPH generation, may trigger the stopping of the tumor cell proliferation and further cell death.
Preprints 77161 g009
Figure 9. Proposed model of the effect of crude extracts from pepper fruits on the antioxidant and redox metabolism of tumor cells. As a consequence of the treatment with pepper extracts an increase of catalase activity and a decline of the NADPH-generation enzymes occurs, thus provoking lower H2O2 levels and limited NADPH availability. Under these circumstances, cell proliferation is arrested and perhaps cell death is triggered. CAT, catalase. SOD, superoxide dismutase. GPX, glutathione peroxidase. GSH, reduced glutathione. GSSG, oxidized glutathione. GR, glutathione reductase. G6PDH, glucose-6-phosphate dehydrogenase. 6PGDH, 6-phosphogluconate dehydrogensase. ICDH, isocitrate dehydrogenase. G6P, glucose-6-phosphate. 6PG, 6-phosphogluconate. Ru5P, ribulose-5-phosphate. αKG, α-ketoglutarate.
Figure 9. Proposed model of the effect of crude extracts from pepper fruits on the antioxidant and redox metabolism of tumor cells. As a consequence of the treatment with pepper extracts an increase of catalase activity and a decline of the NADPH-generation enzymes occurs, thus provoking lower H2O2 levels and limited NADPH availability. Under these circumstances, cell proliferation is arrested and perhaps cell death is triggered. CAT, catalase. SOD, superoxide dismutase. GPX, glutathione peroxidase. GSH, reduced glutathione. GSSG, oxidized glutathione. GR, glutathione reductase. G6PDH, glucose-6-phosphate dehydrogenase. 6PGDH, 6-phosphogluconate dehydrogensase. ICDH, isocitrate dehydrogenase. G6P, glucose-6-phosphate. 6PG, 6-phosphogluconate. Ru5P, ribulose-5-phosphate. αKG, α-ketoglutarate.
Preprints 77161 g009

5. Conclusions

Natural products are commonly considered health sources that can also contribute to prevent cancer and complement targeted therapies. Capsaicin is a compound of alkaloid nature where resides the pungency trait of hot pepper fruits. This chemical has been proven to show antioxidant, anti-inflammatory and analgesic activities, as well as anti-proliferative properties against cancer. However, the results presented in this work show that crude extracts from hot pepper fruits with high capsaicin content do not exhibit anti-proliferative activity against Hep-G2 and MIA PaCa-2 tumor cell lines. Moreover, those tissues which contain little or negligible capsaicin levels displayed the highest anti-proliferative activity. It indicates that other compounds different from capsaicin have this anti-tumor potentiality and, therefore, new research oriented towards the elucidation of the nature of those compounds should be promoted. Thus, a combination of (un)targeted metabolomics and biological assays can contribute to identifying those molecules from pepper fruits with anti-proliferative activity. Those compounds seem to be responsible for the increased catalase activity and lowered NADPH-generating enzyme activities which seems to lead to lower hydrogen peroxide and NADPH levels, thus avoiding cell proliferation and triggering cell death in both cell lines. However, more investigation is necessary to decipher the intimate mechanism exerted by pepper fruit crude extracts. Additionally, the use of purified compounds, once they have been identified from pepper fruits, will allow to envisage new cancer therapies, thus providing a panel of nutraceutical plant products.

Authors’ contribution

M.R.-R., M.C.R., M.J.C., I.D.-S., B.C. and T.A.M. carried out the experimental assays and analyzed the data. F.V. coordinated the biological assays. F.J.C. and J.M.P. designed the work, led and coordinated the tasks and analyzed the data. F.J.C. and J.M.P. wrote the first draft of the manuscript. All authors have read and agreed to the published version of the manuscript.

Acknowledgments

This investigation was supported by the European Regional Development Fund (ERDF)-co-financed grants from the Junta de Andalucía (P18-FR-1359) and the Ministry of Science and Innovation (PID2019-103924GB-I00), Spain. Authors from the Fundación MEDINA are acknowledged for the financial support from this public-private partnership of Merck Sharp & Dohme of Spain S.A., Ltd. with the University of Granada and the Andalusian Regional Government (PIN-0474-2016). Authors acknowledge the different companies and Regulatory Councils of Denomination of Origin for their valuable and generous collaboration providing the different pepper cultivars: California-Melchor by Syngenta Seeds, Ltd., El Ejido, Almería, Spain; Padrón by the Regulatory Council of Denomination of Origin “Pemento de Herbón” (Herbón, A Coruña, Spain), and Piquillo and Alegría riojana, both provided by the Regulatory Council of Denomination of Origin “Pimiento del Piquillo-Lodosa” (Navarra, Spain).

Conflicts of Interests

The authors declare no conflicts of interest.

References

  1. J.E. Klaunik, Oxidative stress and cancer, Curr. Pharm. Des. 24 (2018) 4771-4778. [CrossRef]
  2. F. Tas, H. Hansel, A. Belce, S. Ilvan, A. Argon, H. Camlica, E, Topuz, Oxidative stress in breast cancer, Med. Oncol. 22 (2005) 11-15. [CrossRef]
  3. J. Shen, M.D. Gammon, M.B. Terry, Q. Wang, P. Bradshaw, S.L. Teitelbaum, A.I. Neugut, R.M. Santella, Telomere length, oxidative damage, antioxidants and breast cancer risk, Int. J. Cancer 124 (2009) 1637-1643. 10.1002/ijc.24105.
  4. M.W. Lawless, K.J. O'Byrne, S.G. Gray, Targeting oxidative stress in cancer, Expert Opin. Ther. Targets 14 (2010) 1225-1245. [CrossRef]
  5. L.Y. Tong, C.C. Chuang, S.Y. Wu, L. Zuo, Reactive oxygen species in redox cancer therapy, Cancer Lett. 367 (2015) 18-25. [CrossRef]
  6. H. Forouzandeh, H. Kalantari, N. Saki, Z. Foruozandeh, E. Arefian, A. Farahani, G. Hassani, M.R. Bazrafshan, S. Rasouli, Role of oxidative stress in liver cancer, Clin. Cancer Invest. J. 6 (2017) 1-9. [CrossRef]
  7. M.D. Jelic, A.D. Mandic, S.M. Maricic, B.U. Srdjenovic, Oxidative stress and its role in cancer, J. Cancer Res. Ther. 17 (2021) 22-28. [CrossRef]
  8. E. Cecerska-Heryc, O. Surowska, R.L. Heryc, N. Serwin, S. Napiontek-Balinska, B. Dolegowska, Are antioxidant enzymes essential markers in the diagnosis and monitoring of cancer patients? - A review, Clin. Biochem. 93 (2021) 1-8. [CrossRef]
  9. T.D. Oberley, L.W. Oberley, Antioxidant enzyme levels in cancer, Histol. Histopathol. 12 (1997) 525-535.
  10. J.A. Cockfield, Z.T. Schafer, Antioxidant defenses: a context-specific vulnerability of cancer cells, Cancers 11 (2019) 1208. [CrossRef]
  11. S. George, H. Abrahamse, Redox Potential of antioxidants in cancer progression and prevention, Antioxidants 9 (2020) 1156. [CrossRef]
  12. E. Taucher, I. Mykoliuk, M. Fediuk, F.M. Smolle-Juettner, Autophagy, oxidative stress and cancer development, Cancers 14 (2022) 1637. [CrossRef]
  13. S. Banerjee, Y.W. Li, Z.W. Wang, F.H. Sarkar, Multi-targeted therapy of cancer by genistein, Cancer Lett. 269 (2008) 226-242. [CrossRef]
  14. H. Greenlee, M.L. Kwan, L.H. Kushi, J. Song, A. Castillo, E. Weltzien, C.P. Quesenberry Jr., B.J. Caan, Antioxidant supplement use after breast cancer diagnosis and mortality in the Life After Cancer Epidemiology (LACE) cohort, Cancer 118 (2012) 2048-2058. [CrossRef]
  15. M. Moradi-Joo, S. Heidari, M. Seyed-Nezhad, M.E. Akbari, A. Moosavi, S.H. Davoodi, Antioxidant supplements and breast cancer: a systematic review and meta-analysis, Int. J. Cancer Manag. 11 (2018) 10082. [CrossRef]
  16. V. Jayaprakash, J.R. Marshall, Selenium and other antioxidants for chemoprevention of gastrointestinal cancers, Best Pract. Res. Clin. Gastroenterol. 25 (2011) 507-518. [CrossRef]
  17. X.S. Han, J.J. Li, T.M. Brasky, P.C. Xun, J. Stevens, E. White, M.D. Gammon, K. He, Antioxidant intake and pancreatic cancer risk: The VITamins And Lifestyle (VITAL) study, Cancer 119 (2013) 1314-1320. [CrossRef]
  18. S.K. Saha, S.B. Lee, J. Won, H.Y. Choi, K. Kim, G.M. Yang, A.A. Dayem, S.G. Cho, Correlation between oxidative stress, nutrition, and cancer initiation, Int. J. Mol. Sci. (2017) 1544. [CrossRef]
  19. M. Serafini, P. Jakszyn, L. Lujan-Barroso, A. Agudo, H.B. Bueno-de-Mesquita, F.J.B. van Duijnhoven, M. Jenab, C. Navarro, D. Palli, H. Boeing, Dietary total antioxidant capacity and gastric cancer risk in the European prospective investigation into cancer and nutrition study, Int. J. Cancer. 131 (2012) E544-E554. [CrossRef]
  20. K. Roy, Y.Z. Wu, J.L. Meitzler, A. Juhasz, H. Liu, G.J. Jiang, J.M. Lu, S. Antony, J.H. Doroshow, NADPH oxidases and cancer, Clin. Sci. (London) 128 (2015) 863-875. [CrossRef]
  21. G.M. Rather, A.A. Pramono, Z. Szekely, J.R. Bertino, P.M. Tedeschi, In cancer, all roads lead to NADPH, Pharmacol. Therap. 226 (2021) 107864. [CrossRef]
  22. H.Q. Ju, J.F. Lin, T. Tian, D. Xie, R.H. Xu, NADPH homeostasis in cancer: functions, mechanisms and therapeutic implications. Signal Trans. Targ. Ther. 5 (2020) 231. [CrossRef]
  23. H.C. Yang, Y.H. Wu, W.C. Yen, H.Y. Liu, T.L. Hwang, A. Stern, D.T.Y. Chiu, The Redox role of G6PD in cell growth, cell death, and cancer, Cells 8 (2019) 1055. [CrossRef]
  24. H.C. Yang, A. Stern, D.T.Y. Chiu, G6PD: A hub for metabolic reprogramming and redox signaling in cancer, Biomed. J. 44 (2021) 285-292. [CrossRef]
  25. K.O. Alfarouk, S.B.M. Ahmed, R.L. Elliott, A. Benoit, S.S. Alqahtani, M.E. Ibrahim, A.H.H. Bashir, S.T.S. Alhoufie, G.O. Elhassan, C.C. Wales, L.H. Schwartz, H.S. Ali, A. Ahmed, P.F. Forde, J. Devesa, R.A. Cardone, S. Fais, S. Harguindey, S.J. Reshkin, The pentose phosphate pathway dynamics in cancer and its dependency on intracellular pH, Metabolites 10 (2020) 285. [CrossRef]
  26. T.X. Ge, J.W. Yang, S.H. Zhou, Y.C. Wang, Y.K. Li, X.M. Tong, The role of the pentose phosphate pathway in diabetes and cancer, Front. Endocrinol. 11 (2020) 365. [CrossRef]
  27. R. Li, W. Wan, Y. Yang, C.Y. Gu, Exploring the role of glucose-6-phosphate dehydrogenase in cancer, Oncol. Rep. 44 (2020) 2325-2336. [CrossRef]
  28. S. Liu, T. Cadoux-Hudson, C.J. Schofield, Isocitrate dehydrogenase variants in cancer - Cellular consequences and therapeutic opportunities, Curr. Op. Chem. Biol. 57 (2020) 122-134. [CrossRef]
  29. F.A. Simmen, I. Alhallak, R.M.C. Simmen, Malic enzyme 1 (ME1) in the biology of cancer: it is not just intermediary metabolism, J. Mol. Endocrinol. 65 (2020) R77-R90. [CrossRef]
  30. J.M. Palma, I. Seiquer, To be or not be…an antioxidant? That is the question, Antioxidants 9 (2020) 1234. [CrossRef]
  31. W. Li, J. Li, J. Zhao, C. He, Evolutionary developmental genetics of fruit morphological variation within the Solanaceae, Front. Plant Sci. 6 (2015) 248. [CrossRef]
  32. C. Gebhardt, The historical role of species from the Solanaceae plant family in genetic research, Theor. Appl. Genet. 129 (2016) 2281–2294. [CrossRef]
  33. N. Baenas, N. Belović, N. Ilicb, D.A. Moreno, C. García-Viguera, Industrial use of pepper (Capsicum annum L.) derived products: Technological benefits and biological advantages, Food Chem. 274 (2019) 872–885. [CrossRef]
  34. F.J. Corpas, L. Freschi, J.M. Palma, ROS metabolism and ripening of fleshy fruits, Adv. Bot. Res. 105 (2023) 205-238. [CrossRef]
  35. Y. Wahyuni, A.R. Ballester, E. Sudarmonowati, R.J. Bino, A.G. Bovy, Secondary metabolites of Capsicum species and their importance in the human diet, J. Nat. Prod. 76 (2013) 783–793. [CrossRef]
  36. Y. Li, J. Yao, C. Han, J. Yang, M.T. Chaudhry, S. Wang, H. Liu, Y. Yin, Quercetin, inflammation and immunity, Nutrients 8 (2016) 167. [CrossRef]
  37. M. Reyes-Farias, C. Carrasco-Pozo, The anti-cancer effect of quercetin: Molecular implications in cancer metabolism, Int. J. Mol. Sci. 20 (2019) 3177. [CrossRef]
  38. S. Metsämuuronen, H. Sirén, Bioactive phenolic compounds, metabolism and properties: A review on valuable chemical compounds in Scots pine and Norway spruce, Phytochem. Rev. 18 (2019) 623–664. [CrossRef]
  39. G.E.S. Batiha, A. Alqahtani, A.O. Oluwafemi, H.M. Shaheen, L. Wasef, M. Elzeiny, M. Ismail, M. Shalaby, T. Murata, A. Zaragoza-Bastida, N. Rivero-Perez, A.M. Beshbishy, K.I. Kasozi, P. Jeandet, H.F. Hetta, Biological properties, bioactive constituents, and pharmacokinetics of some Capsicum spp. and capsaicinoids, Int. J. Mol. Sci. 21 (2020) 5179. [CrossRef]
  40. E. Dessalegn, G. Bultosa, G.D. Haki, F. Chen, H.P.V. Rupasinghe, Antioxidant and cytotoxicity to liver cancer HepG2 cells in vitro of Korarima (Aframomum corrorima (Braun) PCM Jansen) seed extracts, Int. J. Food Prop. 25 (2022) 1-10. [CrossRef]
  41. L. Guevara, M.A. Domínguez-Anaya, A. Ortigosa, S. González-Gordo, C. Díaz, F. Vicente, F.J. Corpas, J. Pérez del Palacio, J.M. Palma, Identification of compounds with potential therapeutic uses from sweet pepper (Capsicum annuum L.) fruits and their modulation by nitric oxide (NO), Int. J. Mol. Sci. 22 (2021) 4476. [CrossRef]
  42. E. Cao, J.F. Cordero-Morales, B.Y. Liu, F. Qin, D. Julis, TRPV1 Channels are intrinsically heat sensitive and negatively regulated by phosphoinositide lipids, Neuron 77 (2013) 667-679. [CrossRef]
  43. A.M. Chapa-Oliver, L. Mejía-Teniente, Capsaicin: From plants to a cancer-suppressing agent, Molecules 21 (2016) 931. [CrossRef]
  44. R. Clark, S.H. Lee, Anticancer properties of capsaicin against human cancer. Antican. Res.; 36 (2016) 837-844.
  45. S.R. Georgescu, M.I. Sârbu, C. Matei, M.A. Ilie, C. Caruntu, C. Constantin, M. Neagu M. Tampa, Capsaicin: friend or foe in skin cancer and other related malignancies?, Nutrients 9 (2017) 1365. [CrossRef]
  46. M.A. Tabrizi, P.G. Baraldi, S. Baraldi, S. Gessi, S. Merighi, P.A. Borea, Medicinal chemistry, pharmacology, and clinical implications of TRPV1 receptor antagonists, Medic. Res. Rev. 37 (2017) 936-983. [CrossRef]
  47. F. Yang, J. Zheng, Understand spiciness: mechanism of TRPV1 channel activation by capsaicin, Protein Cell 8 (2017) 169-177. [CrossRef]
  48. K.H. Zhang, D. Julis, Y.F. Cheng, Structural snapshots of TRPV1 reveal mechanism of polymodal functionality, Cell 184 (2021) 5138-5150. [CrossRef]
  49. M.M.G. Karasawa, C. Mohan, Fruits as prospective reserves of bioactive compounds: A review, Nat. Prod. Bioprospect. 8 (2018) 335-346. [CrossRef]
  50. Y. Yoshida, N. Koyama, H. Tamura, Color and anthocyanin composition of strawberry fruit: Changes during fruit development and differences among cultivars, with special reference to the occurrence of pelargonidin 3-malonylglucoside, J. Jpn. Soc. Hortic. Sci. 7 (2020) 355–361. [CrossRef]
  51. J.M. Palma, F. Terán, A. Contreras-Ruiz, M. Rodríguez-Ruiz, F.J. Corpas, Antioxidant profile of pepper (Capsicum annuum L.) fruits containing diverse levels of capsaicinoids, Antioxidants 9 (2020) 878. [CrossRef]
  52. Z. Mao, Z. Liu, L. Chen, J. Yang, B. Zhao, Y.M. Jung, X. Wang, C. Zhao, Predictive value of the surface-enhanced resonance raman scattering-based MTT assay: A rapid and ultrasensitive method for cell viability in situ, Anal. Chem. 85 (2013) 7361-7368. [CrossRef]
  53. P.K. Smith, R.I. Krohn, G.T. Hermanson, A.K. Mallia, F.H. Gartner, M.D. Provenzano, E.K. Fujimoto, N.M. Goeke, B.J. Olson, D.C. Klenk, Measurement of protein using bicinchoninic acid, Anal Biochem. 150 (1985) 76-85. [CrossRef]
  54. H. Aebi, Catalase in vitro, Methods Enzym. 105 (1984) 121–126. [CrossRef]
  55. F.J. Corpas, J.B. Barroso, L.M. Sandalio, S. Distefano, J.M. Palma, J.A. Lupiáñez, L.A. del Río, A dehydrogenase-mediated recycling system of NADPH peroxisomes, Biochem. J. 330 (1998) 777–784. [CrossRef]
  56. F.J. Corpas, J.B. Barroso, L.M. Sandalio, J.M. Palma, J.A. Lupiáñez, L.A. del Río, Peroxisomal NADP-dependent isocitrate dehydrogenase. characterization and activity regulation during natural senescence, Plant Physiol. 121 (1999) 921-928. [CrossRef]
  57. C.M. Beauchamp, I. Fridovich, Superoxide dismutase. Improved assay and an assay applicable to acrylamide gels, Anal. Biochem. 44 (1971) 276–287. [CrossRef]
  58. C.L. Lin, H.J. Chen, W.C. Hou, Activity staining of glutathione peroxidase after electrophoresis on native and sodium dodecyl sulfate polyacrylamide gels, Electrophoresis, 23 (2002) 513-516.
  59. R. Roskoski Jr., ERK1/2 MAP kinases: structure, function, and regulation, Pharmacol. Res. 66 (2012)105-143. [CrossRef]
  60. Raskin, D.M. Ribnicky, S. Komarnytsky, N. Ilic, A. Poulev, N. Borisjuk, A. Brinker, D.A. Moreno, C. Ripoll, N. Yakoby, J.M. O’Neal, T. Cornwell, I. Pastor, B. Fridlender, Plants and human health in the twenty-first century, Trends Biotechnol. 20 (2020) 522-531. [CrossRef]
  61. E. Salmerón-Manzano, J.A. Garrido-Cardenas, F. Manzano-Agugliaro, Worldwide research trends on medicinal plants, Int. J. Environ. Res. Public Health 17 (2020) 3376. [CrossRef]
  62. S. Pattanayak, Plants in healthcare: past, present and future, Explor. Anim. Med. Res. 11 (2022) 140-144. [CrossRef]
  63. J.M. Palma, J. Pérez del Palacio, M. Rodríguez-Ruiz, S. González-Gordo, C. Díaz, María C. Ramos, B. Cautain, F. Vicente, F.J. Corpas, Pepper fruit as a nutraceutical food with antiproliferative activity against tumor cells potentiated by nitric oxide (NO), In: Nitric Oxide in Health and Disease: Therapeutic Applications in Cancer and Inflammatory Disorders (L. Morbidelli, B. Bonavida, J. Muntané, eds.) Academic Press (2023) 193-210.
  64. M. Materska, I. Perucka, Antioxidant activity of the main phenolic compounds isolated from hot pepper fruit (Capsicum annuum L), J. Agric. Food Chem. 53 (2005) 1750-1756. [CrossRef]
  65. R. Roskoski Jr., Targeting ERK1/2 protein-serine/threonine kinases in human cancers, Pharmacol. Res. 142 (2019) 151-168. [CrossRef]
  66. L. Leon, J.F. Jeannin, A. Bettaieb, Post-translational modifications induced by nitric oxide (NO): Implication in cancer cells apoptosis, Nitric Oxide Biol. Chem. 19 (2008) 77-83. [CrossRef]
  67. N.T. Moldogazieva, S.V. Lutsenko, A.A. Terentiev, Reactive oxygen and nitrogen species-induced protein modifications: implication in carcinogenesis and anticancer therapy, Cancer Res. 78 (2018) 6040-6047. [CrossRef]
  68. P. Aguilar-Melero, G. Ferrin, J. Muntané, Effects of nitric oxide synthase-3 overexpres sion on post-translational modifications and cell survival in HepG2 cells, J. Proteomics 75 (2012), 740-755. [CrossRef]
  69. F.J. Corpas, S. González-Gordo, J.M. Palma. Nitric oxide: A radical molecule with potential biotechnological applications in fruit ripening. J Biotechnol. 20 (2020) 211-219. [CrossRef]
  70. Musaogullari, Y.C. Chai, Redox regulation by protein s-glutathionylation: from molecular mechanisms to implications in health and disease, Int. J. Mol. Sci. 21 (2020) 8113. [CrossRef]
  71. D. Pal, A. Rai, R. Checker, R.S. Patwardhan, B. Singh, D. Sharma, S.K. Sandur, Role of protein S-Glutathionylation in cancer progression and development of resistance to anti-cancer drugs, Arch. Biochem. Biophys. 704 (2021) 108890. [CrossRef]
  72. M. Skrzycki, M. Majewska, H. Czeczot, Superoxide dismutase mRNA and protein level in human colorectal cáncer, Cent. Eur. J. Biol. 5 (2010) 590-599. [CrossRef]
  73. M.H. Shah, G.S. Liu, E.W. Thompson, G.J. Dusting, H.M. Peshavariya, Differential effects of superoxide dismutase and superoxide dismutase/catalase mimetics on human breast cancer cells, Breast Cancer Res. Treat. 150 (2015) 523-534. [CrossRef]
  74. M. Liu, X. Sun, B. Chen, R. Dai, Z. Xi, H. Xu, Insights into manganese superoxide dismutase and human diseases. Int. J. Mol. Sci. 23 (2022) 24. [CrossRef]
  75. M.M. Ogle, R. Trevino Jr., J. Schell, M. Varmazyad, N. Horikoshi, D. Gius, Manganese superoxide dismutase acetylation and regulation of protein structure in breast cancer biology and therapy, Antioxidants 11 (2022) 4. [CrossRef]
  76. C. Di Ilio, P. Sacchetta, S. Angelucci, A. Zezza, R. Tenaglia, A. Aceto, Glutathione-peroxidase and glutathione-reductase activities in cancerous and non-cancerous human kidney tissues, Arch. Toxicol. 91 (1995) 19-23. [CrossRef]
  77. J. Gromadzinska, W. Wasowicz, M. Andrijewski, M. Skłodowska, O.Z. Quispe, P. Wołkanin, B. Ołborski, A. Pluzanska, Glutathione and glutathione metabolizing enzymes in tissues and blood of breast cancer patients, Neoplasma 44 (1997) 45-51.
  78. N. Saydam, A. Kirb, O. Demir, E. Hazan, O. Oto, O. Saydam, G. Guner, Determination of glutathione, glutathione reductase, glutathione peroxidase and glutathione S-transferase levels in human lung cancer tissues, Cancer Lett. 119 (1997) 13-19. [CrossRef]
  79. R. Brigelius-Flohé, M. Maiorino, Glutathione peroxidases, Biochim. Biophys. Acta 1830 (2013) 3289-303. [CrossRef]
  80. J.M. Mates, J.A. Campos-Sandoval, J. de los Santos-Jiménez, J. Márquez, Glutaminases regulate glutathione and oxidative stress in cancer, Arch. Toxicol. 94 (2020) 2603-2623. [CrossRef]
  81. Y.J. Zhao, H. Wang, J.D. Zhou, Q.X. Shao, Glutathione peroxidase GPX1 and its dichotomous roles in cancer, Cancers 14 (2022) 2560. [CrossRef]
  82. J.M. Palma, R.M. Mateos, J. López-Jaramillo, M. Rodríguez-Ruiz, S. González-Gordo, A.M. Lechuga-Sancho, F.J. Corpas, Plant catalases as NO and H2S targets. Redox Biol. 34 (2020b) 101525. [CrossRef]
  83. C. Glorieux, N. Dejeans, B. Sid, R. Beck, P.B. Calderon, J. Verrax, Catalase overexpression in mammary cancer cells leads to a less aggressive phenotype and an altered response to chemotherapy, Biochem. Pharmacol. 82 (2011) 1384-1390. [CrossRef]
  84. C. Glorieux, P.B. Calderon, Catalase, a remarkable enzyme: targeting the oldest antioxidant enzyme to find a new cancer treatment approach, Biol. Chem. 398 (2017) 1095-1108. [CrossRef]
  85. M. Galasso, S. Gambino, M.G. Romanelli, M. Donadelli, M.T. Scupoli, Browsing the oldest antioxidant enzyme: catalase and its multiple regulation in cancer, Free Rad. Biol. Med. 172 (2021) 264-272. [CrossRef]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.
Copyright: This open access article is published under a Creative Commons CC BY 4.0 license, which permit the free download, distribution, and reuse, provided that the author and preprint are cited in any reuse.
Prerpints.org logo

Preprints.org is a free preprint server supported by MDPI in Basel, Switzerland.

facebook logotwitter logolinkedin logo
MDPI Initiatives
Important Links
Subscribe

Disclaimer

Terms of Use

Privacy Policy

© 2024 MDPI (Basel, Switzerland) unless otherwise stated